中国药物经济学
中國藥物經濟學
중국약물경제학
CHINA JOURNAL OF PHARMACEUTICAL ECONOMICS
2015年
2期
67-69
,共3页
氨溴索%支气管肺炎%雾化吸入%静脉滴注
氨溴索%支氣管肺炎%霧化吸入%靜脈滴註
안추색%지기관폐염%무화흡입%정맥적주
Ambroxol%Bronchopneumonia%Inhalation%Intravenous infusion
目的:探讨氨溴索雾化吸入和静脉给药对治疗支气管肺炎的疗效。方法选取150例支气管肺炎患者,随机分为两组,各75例。研究组患者给予雾化吸入氨溴索治疗,对照组患者给予静脉滴注氨溴索治疗。比较两组患者的治疗效果。结果研究组患者总有效率为93.3%,明显高于对照组的82.7%;研究组患者临床症状消失时间、住院时间均短于对照组,差异均有统计学意义(均P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论氨溴索雾化吸入治疗支气管肺炎疗效更为确切。
目的:探討氨溴索霧化吸入和靜脈給藥對治療支氣管肺炎的療效。方法選取150例支氣管肺炎患者,隨機分為兩組,各75例。研究組患者給予霧化吸入氨溴索治療,對照組患者給予靜脈滴註氨溴索治療。比較兩組患者的治療效果。結果研究組患者總有效率為93.3%,明顯高于對照組的82.7%;研究組患者臨床癥狀消失時間、住院時間均短于對照組,差異均有統計學意義(均P<0.05)。兩組患者不良反應髮生率比較,差異無統計學意義(P>0.05)。結論氨溴索霧化吸入治療支氣管肺炎療效更為確切。
목적:탐토안추색무화흡입화정맥급약대치료지기관폐염적료효。방법선취150례지기관폐염환자,수궤분위량조,각75례。연구조환자급여무화흡입안추색치료,대조조환자급여정맥적주안추색치료。비교량조환자적치료효과。결과연구조환자총유효솔위93.3%,명현고우대조조적82.7%;연구조환자림상증상소실시간、주원시간균단우대조조,차이균유통계학의의(균P<0.05)。량조환자불량반응발생솔비교,차이무통계학의의(P>0.05)。결론안추색무화흡입치료지기관폐염료효경위학절。
Objective To explore the efficacy ambroxol inhalation and intravenous administration in treatment of bronchopneumonia.Methods We selected 150 cases of bronchial pneumonia patients were randomly divided into two groups,75 cases in each.Patients in study group received atomizing inhalation of ambroxol treatment,patients in control group were treated with intravenous injection of ambroxol.Comparison of the therapeutic effect of two groups of patients.Results Efficiency of 93.3% of the total study group of patients,significantly higher than the control group of 82.7% patients of group;clinical symptoms disappearance time,hospitalization time were less than that in the control group,the difference was statisticaly significant(P<0.05).The occurrence of the two group of adverse reaction rate comparison,no significant difference(P>0.05).Conclusion Effect of ambroxol atomization inhalation in the treatment of bronchial pneumonia is more accurate.